ZCZhi Chen

Zhi Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhi Chen has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Human lung organoids model for assessing host response to Mycobacterium tuberculosis infection

    by Chaofan Li, Pengfei Zhong, Zhimin Yun, Leiming Fang, Meida Xiang, Qisheng Su, Jiru Wang, Hebing Chen, Zhi Chen, Liang Yue, et al.

    Introduction: Airway and alveolar epithelial cells serve as the primary defense in the lower respiratory tract, yet their exact role in Mycobacterium tuberculosis (Mtb) infection is incompletely understood. Given that Mtb is a human-restricted pathogen, a representative human model is required. Lung organoids (LOs), which are composed of various epithelial cells, mesenchymal cells, and extracellular matrix, facilitate the investigation of bacterial infections. Methods: In this study, we established an Mtb infection model using human induced pluripotent stem cells (iPSCs)-derived LOs. Results: Prolonged infection led to the gradual invasion of Mtb from the periphery to the interior of the organoid, leading to decreased viability and the induction of fibrotic responses. Transcriptomic and protein analyses suggest that Mtb infection triggered a TLR4/NF-κB-associated inflammatory response. Additionally, the elevation of antimicrobial peptides and the release of diverse pro-inflammatory cytokines and chemokines were noted in the infected LOs. Conclusion: These findings emphasize the potential role of LOs in host defense and demonstrate that the Mtb -infected lung organoid model provides a novel platform for elucidating the role of pulmonary structural cells in tuberculosis pathogenesis. Furthermore, this model opens new avenues for the development of molecular therapeutic strategies.


  • Open Access

    Evaluation of TST/C-TST combination for latent tuberculosis infection screening: diagnostic performance and cost-effectiveness compared to TST/IGRAs

    by Xin Zhang, Lirong Mao, Renkun Nie, Donglin Guo, Yue Su, Ruilan Wang, Enjun Dong, Yanhui Nie, Hongjuan An, Hengliang Lv, et al.

    The interferon-gamma release assays (IGRAs) are characterized by their complexity and reliance on specific instrumentation. The recombinant Mycobacterium t


  • Open Access

    Assessing Causality Between Endocrine, Nutritional, and Metabolic Disease and Pulmonary Tuberculosis: A Mendelian Randomization Study

    by Yan Gao, Yiguo Wang, Jinwen Su, Chunxia Zhang, Qiming Zhang, Zhi Chen

    Background and Aims: Observational studies frequently report co‐occurrence between endocrine, nutritional, and metabolic disease (ENMD) and pulmonary tuberculosis (PTB). However, the causal properties between them remain poorly defined. Our aim in this study was to investigate the causal effect of ENMD on PTB using Mendelian randomization analysis. Methods: We obtained single nucleotide polymorphisms linked to ENMD, ENMD‐related diseases, and clinical features, as well as PTB, from the IEU OpenGWAS project. Inverse variance weighting was used as the primary analytical method, complemented by Weighted median and MR‐Egger regression to assess their causal relationship. Heterogeneity and horizontal pleiotropy were assessed using Cochran's Q test and MR regression intercepts. The robustness of the results is evaluated by sensitivity analysis leave‐one‐out and MR‐PRESSO. Results: The inverse variance weighting analyses indicated that ENMD significantly increased the risk of PTB (OR = 1.41, 95% CI: 1.18–1.68, p < 0.001) after removing outliers. Interestingly, at the genetic level of European ancestry, there is no evidence of increased risk of PTB with T2DM (OR = 1.05, 95% CI: 0.99–1.12, p = 0.10), whereas high cholesterol (OR = 0.41, 95% CI: 0.22–0.79, p < 0.05), BMI (OR = 0.78, 95% CI: 0.69–0.88, p < 0.001) was negatively correlated with the risk of PTB, and LDL‐c showed a weak inverse correlation with PTB (OR = 0.90, 95% CI: 0.81–0.99, p = 0.03). Sensitivity analyses confirmed the robustness of these findings. Conclusion: This MR study provides novel genetic evidence that ENMD significantly elevates PTB risk. Notably, high cholesterol, BMI, and LDL‐c exhibit protective effects against PTB at the genetic level in European ancestry, while T2DM shows no causal association. These findings highlight the complex role of metabolic factors in tuberculosis susceptibility and suggest potential biological mechanisms linking metabolic dysregulation to PTB pathogenesis.

  • Open Access

    Efficacy and safety of intrathecal dexamethasone combined with isoniazid in the treatment of tuberculous meningitis: a meta-analysis

    by Yan Gao, Jinwen Su, Yuxiang Ma, Yunliang Sun, Jiyong Cui, Xianhe Jin, Yuxi Li, Zhi Chen

    Background: The treatment regimen for tuberculous meningitis (TBM) remains unclear and requires optimization. There are some reports on successful adjunct intrathecal dexamethasone and isoniazid (IDI) treatment strategies for TBM, however, there is equivocal evidence on their efficacy and safety. Methods: A comprehensive search of English and Chinese databases was conducted from inception to February 2024. A meta-analysis was performed on randomized controlled trials (RCTs) estimating the effects of adjunct IDI on conventional anti-TB (C anti-TB) treatments or C anti-TB alone. Efficacy, adverse reaction rate, cerebrospinal fluid (CSF) leukocytes, and CSF protein were used as primary outcome indicators. CSF glucose, CSF chlorides, CSF pressure, recovery time for laboratory indicators and recovery time for clinical symptoms were used as secondary outcome indicators. Results: A total of 17 studies involving 1360 (IDI group vs. C anti-TB group: 392 vs. 372; higher-dose IDI group vs. lower-dose IDI group: 319 vs. 277) patients were included in our analysis. Efficacy was significantly higher (RR 1.3, 95% CI 1.2-1.4, P < 0.001) and adverse reaction rate was significantly lower in the IDI groups (RR 0.59, 95% CI 0.37-0.92, P = 0.021). Furthermore, CSF leukocytes (WMD - 29.33, 95% CI [- 40.64 to-18.02], P < 0.001) and CSF protein (WMD - 0.79, 95%CI [-0.96 to-0.61], P < 0.001) were significantly lower in the IDI groups. Recovery time indicators were all shorter in the IDI groups, fever (SMD - 2.45, 95% CI [-3.55 to-1.35], P < 0.001), coma (SMD-3.75, 95% CI [-4.33 to-3.17], P < 0.001), and headache (SMD - 3.06, 95% CI [- 4.05 to-2.07], P < 0.001), respectively. Higher-dose IDI was more effective than lower-dose IDI (RR 1.23, 95% CI 1.14-1.33, P < 0.001), with no significant difference in adverse reaction rate between the two (RR 0.82, 95%CI 0.43–1.56, P = 0.544). Conclusion: Adjunct IDI with C anti-TB can enhance therapeutic outcomes and reduce adverse reaction rate in adult TBM patients, with higher-dose IDI showing superior efficacy. These findings highlight the potential of IDI as an adjunctive therapy in TBM management. However, more high-quality RCTs from more regions should be conducted to support our results. Trial registration: Retrospectively registered in PROSPERO https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023388860.


  • Top Cited Papers
    Open Access

    Spatial transcriptomic sequencing reveals immune microenvironment features of Mycobacterium tuberculosis granulomas in lung and omentum

    by Xiaochen Qiu, Pengfei Zhong, Liang Yue, Chaofan Li, Zhimin Yun, Guangqian Si, Mengfan Li, Zhi Chen, Yingxia Tan, Pengtao Bao

    Granulomas are a key pathological feature of tuberculosis (TB), characterized by cell heterogeneity, spatial composition, and cellular interactions, which play crucial roles in granuloma progression and host prognosis. This study aims to analyze the transcriptome profiles of cell populations based on their spatial location and to understand the core transcriptome characteristics of granuloma formation and development.


  • Moxifloxacin plus standard first-line therapy in the treatment of pulmonary tuberculosis: A meta-analysis

    by Zhi Chen, Jian-Qin Liang, Jin-He Wang, Shi-Sheng Feng, Guang-Yu Zhang


  • Open Access

    Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis

    by Zhi Chen, Wei Wang, Jianqin Liang, Jinhe Wang, Shisheng Feng, Guangyu Zhang

    Previous studies indicated that the single nucleotide polymorphisms (SNPs) in TLR9 gene might be associated with Tuberculosis (TB) risk. However, the results are inconsistent and inconclusive. 1745 articles from four databases were involved in our study. A meta-analysis on the associations between the seven polymorphisms and TB risk was carried out by comparison using different genetic models. In this systematic review 8 studies from seven English articles were analyzed. Our results showed that rs352139 is significantly associated with TB risk (AA vs. AG, OR 0.77, 95% CI 0.65-0.92, P = 0.004). In the ethnic subgroup analysis, Indonesians with AA genotype had a decreased susceptibility while Mexicans with GG allele had an increased risk. The meta-analysis indicated that rs352139 polymorphism might be associated with decreased TB risk in Indonesians whereas increased risk in Mexicans. Whether the observed association was due to causal effect needs to be further studied.